Emerald Mutual Fund Advisers Trust Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Emerald Mutual Fund Advisers Trust

$1.76 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$83.14 - $145.99 $9 Million - $15.8 Million	-108,256 Reduced 41.18%	154,634 $22.5 Million
Q1 2022 Apr 29, 2022	BUY	$110.08 - $142.92 $254,064 - $329,859	2,308 Added 0.89%	262,890 $31.2 Million
Q4 2021 Feb 02, 2022	BUY	$99.73 - $148.48 $3.51 Million - $5.22 Million	35,181 Added 15.61%	260,582 $35.9 Million
Q3 2021 Oct 28, 2021	BUY	$98.85 - $138.91 $22.3 Million - $31.3 Million	225,401 New	225,401 $31.3 Million
Q1 2021 Apr 29, 2021	SELL	$64.07 - $91.75 $4.88 Million - $6.98 Million	-76,124 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$65.07 - $98.24 $7.14 Million - $10.8 Million	-109,740 Reduced 59.04%	76,124 $6.53 Million
Q3 2020 Oct 28, 2020	SELL	$59.04 - $77.95 $15 Million - $19.7 Million	-253,284 Reduced 57.68%	185,864 $12.1 Million
Q2 2020 Jul 28, 2020	SELL	$29.01 - $74.23 $2.13 Million - $5.44 Million	-73,251 Reduced 14.3%	439,148 $32.1 Million
Q1 2020 Apr 30, 2020	BUY	$27.51 - $57.29 $1.48 Million - $3.08 Million	53,790 Added 11.73%	512,399 $17.4 Million
Q4 2019 Jan 29, 2020	BUY	$40.86 - $57.65 $6.29 Million - $8.88 Million	154,005 Added 50.56%	458,609 $25 Million
Q3 2019 Oct 31, 2019	SELL	$37.38 - $49.47 $53,752 - $71,137	-1,438 Reduced 0.47%	304,604 $12.7 Million
Q2 2019 Jul 31, 2019	SELL	$39.79 - $67.01 $7.63 Million - $12.8 Million	-191,679 Reduced 38.51%	306,042 $13.4 Million
Q1 2019 May 01, 2019	BUY	$34.52 - $53.29 $600,751 - $927,405	17,403 Added 3.62%	497,721 $25.6 Million
Q4 2018 Jan 31, 2019	BUY	$29.75 - $42.9 $339,893 - $490,132	11,425 Added 2.44%	480,318 $17.8 Million
Q3 2018 Oct 31, 2018	BUY	$32.79 - $43.0 $4.04 Million - $5.29 Million	123,103 Added 35.6%	468,893 $17.6 Million
Q2 2018 Jul 31, 2018	BUY	$23.62 - $42.29 $453,102 - $811,249	19,183 Added 5.87%	345,790 $13.7 Million
Q1 2018 Apr 26, 2018	BUY	$22.49 - $34.56 $969,521 - $1.49 Million	43,109 Added 15.21%	326,607 $8.41 Million
Q4 2017 Feb 06, 2018	BUY	$20.44 - $35.56 $1.7 Million - $2.96 Million	83,312 Added 41.62%	283,498 $7.65 Million
Q3 2017 Oct 30, 2017	BUY	$23.54 - $38.21 $4.71 Million - $7.65 Million	200,186	200,186 $7.48 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account